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Introduction
Breast phyllodes tumors are rare neoplasms which present
challenges for histological classification. Microscopic fea-
tures are not always predictive of clinical behavior, and
scarce data exist on the prognostic role of biological mar-
kers. Our study evaluated a series of 145 phyllodes tumors
diagnosed at the Department of Pathology, Singapore
General Hospital between 2006 and 2009, incorporating
91 (62.8%) benign, 40 (27.6%) borderline, and 14 (9.7%)
malignant phyllodes tumors.
Methods
Antibodies to keratin 15 (KRT15), transcobalamin I
(TCN1), and homeobox gene Hox-B13 (HOXB13) were
applied to sections cut from tissue microarray blocks.
KRT15 and TCN1 positivity was defined when there was
reactivity of 1% or more stromal cells, while HOXB13
positivity was defined using a H-score of 100 and above.
Results
Positive immunohistochemical expression for KRT15,
TCN1, and HOXB13 was seen in 21 (14.5%), 96 (66.2%),
and 66 (45.5%) of tumors, respectively. Stromal expression
of KRT15, TCN1, and HOXB13 was significantly corre-
lated with tumor grade (P<0.001, P<0.001, P = 0.012), stro-
mal hypercellularity (P = 0.005, P<0.001, P = 0.023),
mitotic activity (P<0.001), and microscopic borders (P =
0.006, P<0.001, P = 0.011).
Conclusions
Co-expression of TCN1 and HOXB13 was seen in 21 of
91 (23.1%) benign, 18 of 40 (45.0%) borderline, and 11 of
14 (78.6%) malignant tumors, suggesting that the dual-
marker panels of TCN1 and HOXB13 might be helpful in
classifying borderline and malignant tumors. Although
expression of TCN1 alone was present in all malignant
and 34 of 40 (85.0%) borderline tumors, a combined panel
with HOXB13 excluded some benign cases and was a bet-
ter discriminant for a significant proportion of borderline
and malignant tumors.
Author details
1Royal College of Surgeons in Ireland, Ireland. 2Singapore General Hospital,
Singapore.
Published: 9 July 2012
doi:10.1186/1753-6561-6-S4-P21
Cite this article as: Chong and Tan: Keratin 15, transcobalamin I and
homeobox gene Hox-B13 expression in breast phyllodes tumors: novel
markers in biological classification. BMC Proceedings 2012 6(Suppl 4):P21.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1Royal College of Surgeons in Ireland, Ireland
Full list of author information is available at the end of the article
Chong and Tan BMC Proceedings 2012, 6(Suppl 4):P21
http://www.biomedcentral.com/1753-6561/6/S4/P21
© 2012 Chong and Tan; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
